JulieRGralowMD

PubMed

• Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO.
  Maria T Bourlon, Ami S Bhatt, Gilberto Lopes, Fredrick Chite Asirwa, Alexandru E Eniu, Lawrence N Shulman, Julia Close, Jamie Von Roenn, Michal Tibbits, Doug Pyle, Pat...> ;JCO Global Oncology. 2024 Apr 1
• 2 citations
  Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
  Maddula, S., Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K Cheng, Generika Berman, Catherine H Marshall, Avirup Guha, Prantesh Jain, Austin Steward, Jeanne...> ;American Heart Journal Plus. 2024 Feb 1
• 1 citations
  Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study.
  Megan McLeod, Julie Torode, Kari Leung, Nirmala Bhoo-Pathy, Christopher Booth, Jade Chakowa, Julie Gralow, Andre Ilbawi, Jacek Jassem, Jeannette Parkes, Merixtell Mall...> ;The Lancet. Oncology. 2024 Feb 1
• 2 citations
  Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
  Anum S Kazerouni, Lanell M Peterson, Isaac Jenkins, Alena Novakova-Jiresova, Hannah M Linden, Julie R Gralow, David M Hockenbery, David A Mankoff, Peggy L Porter, Sava...> ;Breast Cancer Research. 2023 Nov 9
• 1 citations
  Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities.
  Kari Leung, Megan McLeod, Julie Torode, André Ilbawi, Jade Chakowa, Brian Bourbeau, Manju Sengar, Christopher M Booth, Julie R Gralow, Richard Sullivan, Ajay Aggarwal> ;European Journal of Cancer. 2023 Dec 1
• Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.
  Brooke E Wilson, Richard Sullivan, Richard Peto, Bello Abubakar, Christopher Booth, Gustavo Werutsky, Cary Adams, Agnes Saint-Raymond, Thomas R Fleming, Kim Lyerly, Ju...> ;JCO Global Oncology. 2023 Sep 1
• 1 citations
  Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets.
  Samer El Kababji, Nicholas Mitsakakis, Xi Fang, Ana-Alicia Beltran-Bless, Greg Pond, Lisa Vandermeer, Dhenuka Radhakrishnan, Lucy Mosquera, Alexander Paterson, Lois Sh...> ;JCO Clinical Cancer Informatics. 2023 Sep 1
• Effects ofandgenotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.
  Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg, Kathy S Albain, Shaker R Dakhil, Nagendra R Tirumali, Julie R Gralow, G...> ;Pharmacogenomics. 2023 Aug 1
• 3 citations
  Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.
  Rikki A Cannioto, Kristopher M Attwood, Evan W Davis, Lucas A Mendicino, Alan Hutson, Gary R Zirpoli, Li Tang, Nisha M Nair, William Barlow, Dawn L Hershman, Joseph M ...> ;JAMA Network Open. 2023 May 1
• 1 citations
  ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology.
  Gladys Rodriguez, Joan Mancuso, Gary H Lyman, Fatima Cardoso, Zeina Nahleh, Julie M Vose, Julie R Gralow, Michael Francisco, Shimere Sherwood> ;JCO Oncology Practice. 2023 Jul 1
• 3 citations
  Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Cl...
  Dax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, M Kelsey Kirkwood, Natalie Dickson, Trupti Hattiangadi, Kathryn F Mileham, Alicia Patrick, Jen Hanley Williams,...> ;Cancer. 2023 Jun 1
• 2 citations
  Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
  Mattias Bergqvist, Adrian Nordmark, Amy Williams, Costanza Paoletti, William Barlow, Erin F Cobain, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain,...> ;Biomarkers. 2023 May 1
• 14 citations
  Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo...
  Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla, Carey K Anders, Lori Goldstein, Debu Tripathy, Ursa A Brown-Glaberman, Thu-Tam Huynh,...> ;The Lancet. Oncology. 2023 Feb 1
• 438 citations
  Current and future burden of breast cancer: Global statistics for 2020 and 2040.
  Melina Arnold, Eileen Morgan, Harriet Rumgay, Allini Mafra, Deependra Singh, Mathieu Laversanne, Jerome Vignat, Julie R Gralow, Fatima Cardoso, Sabine Siesling, Isabel...> ;Breast. 2022 Dec 1
• 8 citations
  Cancer research across Africa: a comparative bibliometric analysis.
  Miriam Mutebi, Grant Lewison, Ajay Aggarwal, Olusegun Isaac Alatise, Christopher Booth, Miska Cira, Surbhi Grover, Ophira Ginsburg, Julie Gralow, Serine Gueye, Benda K...> ;BMJ Global Health. 2022 Nov 1
• 3 citations
  Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating ...
  Darya Kizub, Cathyryne K Manner, Katy Graef, Bello Abubakar, Jackson Orem, Folakemi Odedina, Mojisola Christianah Adeyeye, Gertrude Nakigudde, Kassa Ayalew, Chitkala K...> ;JCO Global Oncology. 2022 Jun 1
• 47 citations
  Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research S...
  Randall A Oyer, Patricia Hurley, Leigh Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine Barrett, Al Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jenn...> ;Journal of Clinical Oncology. 2022 Jul 1
• 1 citations
  Reduced Cancer-Related Fatigue after Tablet-Based Exercise Education for Patients.
  Diana J Wilkie, Anna L Schwartz, Wen-Chun Liao, Dottington Fullwood, Yu Wu, Tanya Wallace Farquharson, Yingwei Yao, Julie R Gralow> ;Cancer Control. 2022 Apr 13
• 4 citations
  Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement.
  Richard Sullivan, Grant Lewison, Julie Torode, Peter T Kingham, Murray Brennan, Lawrence N Shulman, Mark Lawler, Ajay Aggarwal, Julie Gralow> ;The Lancet. Oncology. 2022 Apr 1
• 28 citations
  Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positiv...
  Ian E Krop, Seock-Ah Im, Carlos Barrios, Hervé Bonnefoi, Julie Gralow, Masakazu Toi, Paul A Ellis, Luca Gianni, Sandra M Swain, Young-Hyuck Im, Michelino De Laurentiis...> ;Journal of Clinical Oncology. 2022 Feb 10
• 264 citations
  21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
  Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nan Lin, Edith A. Perez, Lori J. Goldstein, Stephen Chia, S...> ;The New England Journal of Medicine. 2021 Dec 1
• 4 citations
  A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.
  Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James W. Hicks, Lisa Welter, Philip A. Dy, Christina ...> ;Clinical Cancer Research. 2021 Nov 29
• 3 citations
  Case report of sacituzumab govitecan-hziy-induced neutropenia in a patient with metastatic triple-negative breast cancer and a uridine diphosphate glucuronosyltransfer...
  Grace Baek, Lindsey Jung, Arianne Duong, Julie Gralow> ;Journal of Oncology Pharmacy Practice. 2021 Nov 11
• 12 citations
  Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry.
  Kathryn Finch Mileham, Suanna S. Bruinooge, Charu Aggarwal, Alicia L. Patrick, Christiana Davis, Daniel J Mesenhowski, Alexander I. Spira, Eric J. Clayton, David M. Wa...> ;JCO Oncology Practice. 2021 Oct 25
• 7 citations
  Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.
  Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka S...> ;Clinical Cancer Research. 2021 Sep 14
• Join now to see all

Journal Articles

• Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230  
  Carol J Fabian, Julie R Gralow, Journal of the National Cancer Institute
• Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer  
  Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
• The Induction of Leu-1 Antigen Expression in Human Malignant and Normal B-Cells by Phorbol Myristic Acetate.  
  Miller RA, Gralow J, Journal of Immunology
• Biclonal B-Cell Lymphoma.  
  Sklar J, Cleary ML, Thielmans K, Gralow J, Warnke R, Levy R, New England Journal of Medicine
• Strategies for the Production of Monoclonal Anti-Idiotype Antibodies Against Human B-Cell Lymphomas.  
  Thielmans K, Maloney DG, Meeker T, Fujimoto J, Doss C, Gralow J, Miller RA, Levy R, Journal of Immunology
• The Optimal Application of Forward and Ninety-Degree Light Scatter in Flow Cytometry for the Gating of Mononuclear Cells.  
  Thompson JM, Gralow J, Levy R, Miller RA, Cytometry
• Southern Blot Analysis of DNA Extracted from Formalin-Fixed Pathology Specimens.  
  Dubeau LA, Chandler L, Gralow J, Nichols PW, Jones PA, Cancer Research
• Studies on B Lymphoid Tumors Treated with Monoclonal Anti-idiotype Antibodies: Correlation with Clinical Responses.  
  Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R, Blood
• In Vitro Tests that Predict Tumor-Associated Idiotype Levels in the Serum of Patients with B Cell Lymphomas and Leukemias.  
  Miller RA, Lowder JN, Gralow J, Meeker T, Levy R, Blood
• Immunity to Oncogenic Proteins.  
  Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi, M, and Chen W, Imm Rev
• -CSF: An Effective Adjuvant for Protein and Peptide Based Vaccines.  
  Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, and Cheever MA, Blood
• Peptide Based, but Not Whole Protein, Vaccines Elicit Immunity to HER-2/neu, an Oncogenic Self-Protein.  
  Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA, J Immunology
• Combining Complementary and Conventional Therapies in Medical Practice: A Medical Oncologist’s Perspective.  
  Gralow JR, Northwest Physician
• Dose-Intensive Vinorelbine with Concurrent Granulocyte Colony-Stimulating Factor Support in Paclitaxel-Refractory Metastatic Breast Cancer.  
  Livingston RB, Ellis GK, Gralow JR, Williams MA, White R, McGuirt S, Adamkiewicz BB, Long CA, J Clin Oncol
• Gene Therapy for Breast and Ovarian Cancer with BRCA1.  
  Tait DL, Jensen RA, Gralow, J, King, MC, Johnson DH, Holt, JT, Breast Disease
• High-titer HER-2/neu Protein-specific Antibody Can Be Detected in Patients with Early-stage Breast Cancer.  
  Disis ML, Pupa SM, Gralow, JR, Dittadi R, Menard S, Cheever MA, J Clin Oncol
• A Multidisciplinary Approach to Locoregional Management of the Axilla for Primary Operable Breast Cancer.  
  Anderson BO, Austin-Seymour MM, Gralow JR, Moe RE, Byrd DR, Cancer Control
• Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.  
  Clark JI, Alpaugh RK, von Mehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM, Cancer Immunol Immunother
• Anthropometric and Hormone Effects of an 8-week Exercise-Diet Intervention in Breast Cancer Patients: Results of a Pilot Study.  
  McTiernan A, Kumai C, Bean D, Schwartz R, Ulrich C, Mahloch J, Hastings R, Gralow J, Potter J, Cancer Epidemiology
• The value of combined FDG-PET and magnetic resonance imaging in the evaluation of suspected local-regional breast cancer: preliminary experience.  
  Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Gralow JR, Cortese AA, Hayes, CE, Moe RE, Radiology
• Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: High complete response rate in a phase I-II study i...  
  Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB, J Clin Oncol
• Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.  
  Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston RB, Cancer
• Herceptin for the treatment of metastatic breast cancer.  
  Gralow, JR, Curr Practice Med
• Participation in breast cancer risk counseling among women with a family history.  
  Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, Gralow J, Malone K, Cancer Epidemiol Biomarkers Prev
• Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.  
  Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Austin Seymour MM, Int J Radiat Oncol Biol Phys
• Join now to see all

Books/Book Chapters

• Medical Therapeutics. 
  Chapter: Oncologic Therapeutics 
  Gralow JR, Livingston RL, Hunt K, Petersdorf SEditors: Ramsey P and Larson EB.W.B. Saunders Co
• Cancer Patient Follow-Up. 
  Chapter: Breast Cancer Patient Follow-Up 
  Gralow JR, Anderson BOEditors: Johnson, F. and Virgo, K.S.Moseby-Year Book, Inc
• Vaccines Against Virally Induced Cancers. 
  Chapter: Immunity to the HER-2/neu Oncogenic Protein 
  Page 198 - 211Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MAJohn Wiley & Sons, Inc
• Proceedings of the Second International Conference on Malignant Lymphoma. 
  Chapter: The Immunology of B-Cell Lymphoma. Studies with Anti-Idiotype Antibodies 
  Levy R, Meeker TC, Lowder JN, Maloney D, Thielmans K, Gralow J, Warnke R, Cleary ML, Sklar JMartinus Nishoff Publishing, Boston, MA
• Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide. 
  Gralow JRPeanut Butter Publishing
• Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide. 
  Gralow JREditors: Susan G.Komen Breast Cancer FoundationEdition 3rd,
• Diseases of the Breast. 
  Chapter: Adjuvant Systemic Therapy: Bisphosphonates 
  Gralow JREditors: Harris JR, Lippman ME, Morrow M, Osborne CK.Lippincott, Williams & WilkinsEdition 4th,
• Principles and Practice of Fertility Preservation. 
  Chapter: Breast cancer therapy and reproduction 
  Page 62 - 72Korde L, Gralow JREditors: Donnez J and Kim SS.Cambridge University Press
• Cancer rehabilitation and survivorship: Transdisciplinary approaches to personalized care. 
  Chapter: Recurrence and second primary cancers 
  Koon KP, Gralow JREditors: J.L. Lester & P. Schmitt.Oncology Nursing Society, Pittsburgh, PA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Core elements for provision of cancer care and control in low and middle income countries 
  Shulman L, Gralow J, Krakauer E, Anderson BO, Porter P, Gospodarowicz M, Feldman S, Rodriguez-Galindo C, Frazier L, Lehmann LEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Innovative delivery of cancer care and control in low-resource scenarios 
  Knaul FM, Bhadelia A, Gralow J, Langer AEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Access to affordable medicines, vaccines, and health technologies for cancer: overcoming price and non-price barriers to access 
  Quick J, Konduri N, Gralow JEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: An Equity Imperative. 
  Knaul FM, Gralow JR, Atun R, Bhadelia AHarvard University Press, Boston, MA
• Join now to see all

Abstracts/Posters

• Prediction of 10-Year Chemotherapy Benefit and Breast Cancer-Specific Survival by the 21-Gene Recurrence Score (RS) Assay in Node-Positive, ER-Positive Breast Cancer–A...
  Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh I-T, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, P..., San Antonio Breast Cancer Symposium
• Do the ASCO/CAP 2007 HER2 Testing Guidelines Improve Prediction of Benefit to Adjuvant Trastuzumab?
  Perez EA, Reinholz MM, Dueck AC, Tenner KS, Davidson NE, Gralow J, Harris L, Kutteh L, Jenkins RB, Chen B, San Antonio Breast Cancer Symposium
• Variants in the BRCA1/Fanconi-Anemia Repair Pathway and Taxane-Induced Neuropathy in SWOG S0221.
  Ambrosone CB, Sucheston LE, Zhao H, Yao S, Budd GT, Barlow WE, Hershman DL, Davis W, Ciupak G, Stewart JA, Isaacs C, Hobday T, Latreille J, Hortobagyi GN, Gralow JR, L..., San Antonio Breast Cancer Symposium
• The Influence of Older Age on Physician and Patient Decision-Making Regarding Enrollment to Breast Cancer Clinical Trials.
  Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, Lara PN, Williams PA, Hutchins LF, Gotay CC, Albain KS, San Antonio Breast Cancer Symposium
• c-MYC (MYC) Protein Expression and Associations with Trastuzumab Benefit in Early-Stage, HER2+ Breast Cancer in Context of the NCCTG Adjuvant Trial, N9831.
  Reinholz MM, Dueck AC, Wiktor AE, Lingle WL, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Kutteh LA, Sledge GW, Harris LN, Gralow JR, Geiger X, Perez EA, San Antonio Breast Cancer Symposium
• Effect of IGF1R protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG N9831 trial.
  Reinholz MM, Dueck AC, Chen B, Geiger X, McCullough AE, Jenkins RB, Lingle WL, Andorfer C, Davidson NE, Martino S, Kaufman PA, Kutteh LA, Sledge GW, Harris L, Gralow J..., J Clin Oncol
• SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, ho...
  Gonzalez-Angulo AM, Barlow WE, Gralow J, Meric-Bernstam F, Hayes DF, Moinpour C, Ramsey SD, Schott AF, Sparks DB, Albain KS, Hortobagyi GN, J Clin Oncol
• Effect of PTEN protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG adjuvant trial N9831.
  Perez EA, Dueck AC, Reinholz MM, Chen B, Geiger X, Jenkins RB, Lingle WL, Andorfer C, Davidson NE, Martino S, Kaufman PA, Kutteh LA, Sledge GW, Harris L, Gralow J, Mc..., J Clin Oncol
• First analysis of SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early breast cancer.
  Budd GT, Barlow WE, Moore HC, Hobday TJ, Stewart JA, C. Isaacs C, M. Salim M, J. K. Cho JK, K. Rinn K, K. S. Albain KS, H. K. Chew HK, Burton GV, Moore TD, Srkalovic G..., J Clin Oncol
• Changes in FDG PET SUV and correlation with Ki-67 following 2 weeks of aromatase inhibitor therapy or trastuzumab in a pilot imaging study.
  Linden HM, Kurland BF, Livingston RB, Ellis GK, Gadi VK, Specht JM, Gralow J, Peterson L, Schubert EK, Xiaoyu S, Mankoff DA, J Clin Oncol
• Discordance between Central and Local Laboratory HER2 Testing from a Large HER2-Negative Population in VIRGO, a Metastatic Breast Cancer Registry.
  Vogel CL, Bloom K, Burris H, Gralow JR, Mayer M, Pegram M, Rugo HS, Swain SM, Yardley DA, Chau M, Lalla D, Brammer MG, Kaufman PA, San Antonio Breast Cancer Symposium
• Spontaneous and Induced Immunoglobulin Secretion and Differentiation in Human B-Cell Lymphomas and Leukemias.
  Gralow J, Levy R, Miller RA, Federation Proceedings, Federation of American Societies for Experimental Biology
• A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.
  Mehta RS, Barlow WE, Albain KS, Vandenberg T, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN, San Antonio Breast Cancer Symposium
• Southern Blotting of DNA from Formalin-Fixed, Paraffin Embedded Tissue.
  Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, International Academy of Pathology
• Recovery of Intact, High Molecular Weight DNA from Formalin-Fixed, Paraffin Embedded Pathology Specimens.
  Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, American Urological Association
• NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen ...
  Paterson AHG, Anderson SJ, Lembersky BC, Fehrenbacher L, Falkson CI, King KM, Weir LM, Brufsky AM, Dakhil S, Lad T, Baez-Diaz L, Gralow JR, Robidoux A, Perez EA, Zheng..., San Antonio Breast Cancer Symposium
• Methylation Patterns of the Alpha-Lactalbumin Gene in Human Mammary Carcinoma: A Model for Identification of the Origin of Metastatic Tumors.
  Gralow JR, Dubeau L, Jones PA, Clinical Research
• Existent T cell and Antibody Immunity to HER-2/neu Protein in Breast Cancer Patients.
  Disis ML, Bernhard H, Gralow JR, Cheever MA, The American Association for Cancer Research
• Impact of Quantitative Measurement of HER2, HER3, HER4, EGFR, ER and PTEN Protein Expression on Benefit to Adjuvant Trastuzumab in Early-Stage HER2+ Breast Cancer Pati...
  Perez EA, Ballman KV, Reinholz MM, Dueck AC, Cheng H, Jenkins RB, McCullough AE, Chen B, Davidson NE, Martino S, Kaufman PA, Kutteh LA, Sledge GW, Geiger XJ, Ingle JN,..., San Antonio Breast Cancer Symposium
• Immunization to oncogenic HER-2/neu protein with peptide based vaccines.
  Disis ML, Gralow JR, Bernhard H, Hand S, and Cheever MA, The American Association for Cancer Research
• Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
  Bernhard H, Disis ML, Huseby E, Hand S, Gralow JR, Risdon G, Heimfeld S, and Cheever MA, Keystone Symposia
• Pooled Analysis of Individual Patient Data from Capecitabine Monotherapy Clinical Trials in Anthracycline-/Taxane-Pretreated Locally Advanced or Metastatic Breast Canc...
  Blum JL, Barrios CH, Feldman N, Verma S, McKenna E, Lee S, Scotto N, Gralow J, San Antonio Breast Cancer Symposium
• HER-2/neu Specific Immunity Can Be Induced by Therapy with 2B1, a Bispecific Antibody Binding to HER-2/neu and CD16.
  Gralow JR, Weiner LM, Ring D, Clark J, Alpaugh RK, Disis ML, Cheever MA, IVth International Conference on Bispecific Antibodies and Targeted Cellular Toxicity
• A Randomized Phase III Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients (pts) with 1-3 Positive Nodes, Hormone Receptor (HR)-Positive...
  Gonzalez-Angulo AM, Barlow WE, Gralow JR, Meric-Bernstam F, Hayes DF, Moinpour CM, Ramsey SD, Schott AF, Sparks DB, Albain KS, Hortobagyi GN, San Antonio Breast Cancer Symposium
• GM-CSF: An effective adjuvant for peptide based vaccines.
  Disis ML, Bernhard H, Shiota F, Hand S, Gralow JR, and Cheever MA, The Ninth International Congress of Immunology
• Join now to see all

Lectures

• What Is Implementation Science and the Breast Cancer Initiative 2.5 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018